CHTH · As filed with the SEC
CNL Healthcare Properties income statement, by fiscal year
The statement as CNL Healthcare Properties presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF OPERATIONS · USD thousands, except per-share amounts; shares in thousands
| USD thousands, except per-share amounts; shares in thousands | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 |
|---|---|---|---|---|
| Revenues: | ||||
| Rental income and related revenues | — | 26,920 | 26,862 | 30,101 |
| Rental income and related revenues | 27,298 | — | — | — |
| Resident fees and services | 338,662 | 314,560 | 295,799 | 265,321 |
| Total revenues | 365,960 | 341,480 | 322,661 | 295,422 |
| Operating expenses: | ||||
| Property operating expenses | 245,537 | 235,524 | 226,845 | 197,562 |
| General and administrative expenses | 8,759 | 9,101 | 10,209 | 9,116 |
| Asset management fees | 13,353 | 13,856 | 14,074 | 15,733 |
| Property management fees | 16,712 | 15,438 | 14,703 | 12,981 |
| Financing coordination fees | 0 | 2,671 | — | 0 |
| Impairment provision | — | 0 | 0 | 9,790 |
| Depreciation and amortization | 50,689 | 51,234 | 54,242 | 50,417 |
| Total operating expenses | 335,050 | 327,824 | 320,073 | 295,599 |
| Gain on sale of real estate | 0 | 0 | 6,282 | 0 |
| Operating income | 30,910 | 13,656 | 8,870 | (177) |
| Other income (expense): | ||||
| Interest and other income | 1,141 | 3,113 | 4,663 | 720 |
| Interest expense and loan cost amortization | (45,858) | (41,873) | (21,781) | (19,696) |
| Gain on change of control of a joint venture | 0 | 0 | 8,376 | — |
| Equity in earnings of unconsolidated entity | — | 0 | 0 | 471 |
| Nonoperating Income (Expense), Total | (44,717) | (38,760) | (8,742) | (18,505) |
| (Loss) income before income taxes | (13,807) | (25,104) | 128 | (18,682) |
| Income tax expense | (611) | (560) | (540) | (4,174) |
| Loss from continuing operations | — | (25,664) | (412) | (22,856) |
| Loss from discontinued operations | — | 0 | 0 | (10) |
| Net loss | (14,418) | (25,664) | (412) | (22,866) |
| Less: Amounts attributable to noncontrolling interests | 44 | 34 | 1,041 | 16 |
| Net income from discontinued operations | — | — | — | 0 |
| Net loss attributable to common stockholders | (14,462) | (25,698) | (1,453) | (22,882) |
| Continuing operations | — | — | — | (0.13) |
| Weighted average number of shares of common stock outstanding (basic and diluted) | — | — | — | 173,960,000 |
| Continuing operations, basic (in dollars per share) | — | (0.15) | (0.01) | — |
| Continuing operations, diluted (in dollars per share) | — | (0.15) | (0.01) | — |
| Discontinued operations, basic (in dollars per share) | — | 0.00 | 0.00 | — |
| Discontinued operations, diluted (in dollars per share) | — | 0.00 | 0.00 | — |
| Net loss per share of common stock, basic (in dollars per share) | (0.08) | — | — | — |
| Net loss per share of common stock, diluted (in dollars per share) | (0.08) | — | — | — |
| Weighted average number of shares of common stock outstanding, basic (in dollars per share) | 173,942 | 173,958 | 173,960 | — |
| Weighted average number of shares of common stock outstanding, diluted (in dollars per share) | 173,942 | 173,958 | 173,960 | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.